A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-23
DOI
10.1038/s41467-022-31259-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
- (2022) Rana Abdelnabi et al. ANTIVIRAL RESEARCH
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
- (2022) Peter J. Halfmann et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion
- (2022) Frederic Grabowski et al. Viruses-Basel
- Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
- (2022) Baisheng Li et al. Nature Communications
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
- (2022) Juliet R. C. Pulliam et al. SCIENCE
- Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
- (2022) Tongqing Zhou et al. SCIENCE
- Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
- (2022) Qiaoli Peng et al. EBioMedicine
- Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
- (2021) Zhiqiang Ku et al. Nature Communications
- Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
- (2021) Dongyan Zhou et al. Cell Host & Microbe
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
- (2021) Pengfei Wang et al. Cell Host & Microbe
- Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
- (2021) Guo-Lin Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters
- (2021) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
- (2021) Aaron J. Schmitz et al. IMMUNITY
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
- (2021) Rita E. Chen et al. NATURE
- The biological and clinical significance of emerging SARS-CoV-2 variants
- (2021) Kaiming Tao et al. NATURE REVIEWS GENETICS
- Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
- (2021) Tzu-Jing Yang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
- (2021) Lingshu Wang et al. SCIENCE
- Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
- (2021) Meng Yuan et al. SCIENCE
- Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
- (2021) Timothy J. C. Tan et al. Nature Communications
- Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
- (2021) Qi Zhang et al. Nature Communications
- COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
- (2021) Jinhui Dong et al. Nature Microbiology
- Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients
- (2021) Lu Lu et al. CLINICAL INFECTIOUS DISEASES
- Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021
- (2021) Laura Espenhain et al. Eurosurveillance
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
- (2021) Wanwisa Dejnirattisai et al. LANCET
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2021) Lihong Liu et al. NATURE
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
- (2021) Elisabetta Cameroni et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2021) Sandile Cele et al. NATURE
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues
- (2021) Naushad Ahmad Khan et al. Travel Medicine and Infectious Disease
- Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens
- (2020) Jasper Fuk-Woo Chan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)
- (2020) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
- (2020) Kelvin Kai-Wang To et al. CLINICAL INFECTIOUS DISEASES
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
- (2020) M. Alejandra Tortorici et al. SCIENCE
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- New tools for automated high-resolution cryo-EM structure determination in RELION-3
- (2018) Jasenko Zivanov et al. eLife
- GISAID: Global initiative on sharing all influenza data – from vision to reality
- (2017) Yuelong Shu et al. Eurosurveillance
- MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
- (2017) Shawn Q Zheng et al. NATURE METHODS
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- UCSF ChimeraX: Meeting modern challenges in visualization and analysis
- (2017) Thomas D. Goddard et al. PROTEIN SCIENCE
- Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor
- (2016) Leopold Kong et al. IMMUNITY
- SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
- (2014) Marco Biasini et al. NUCLEIC ACIDS RESEARCH
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
- (2009) Kenneth Smith et al. Nature Protocols
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started